{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:14:50Z","timestamp":1792793690066,"version":"4.5.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ijantimicag.2026.107808","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T06:15:00Z","timestamp":1776233700000},"page":"107808","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["In vivo emergence of cross-resistance to ceftazidime\/avibactam and cefiderocol through selection of KPC variants in Klebsiella pneumoniae clinical isolates"],"prefix":"10.1016","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8180-5075","authenticated-orcid":false,"given":"Gabriele","family":"Bianco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7335-9001","authenticated-orcid":false,"given":"Jacqueline","family":"Findlay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Comini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1343-1622","authenticated-orcid":false,"given":"Patrice","family":"Nordmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6726-2716","authenticated-orcid":false,"given":"Matteo","family":"Boattini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2026.107808_bib0001","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/1469-0691.12719","article-title":"The difficult-to-control spread of carbapenemase producers among enterobacteriaceae worldwide","volume":"20","author":"Nordmann","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2026.107808_bib0002","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.3390\/microorganisms13071697","article-title":"Global epidemiology and antimicrobial resistance of Klebsiella pneumoniae carbapenemase (KPC)-producing gram-negative clinical isolates: a review","volume":"13","author":"Falagas","year":"2025","journal-title":"Microorganisms"},{"key":"10.1016\/j.ijantimicag.2026.107808_bib0003","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/cid\/ciy492","article-title":"Efficacy of ceftazidime-avibactam salvage therapy in patients with infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae","volume":"68","author":"Tumbarello","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107808_bib0004","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s10096-023-04577-x","article-title":"Rapid diagnostics and ceftazidime\/avibactam for KPC-producing Klebsiella pneumoniae bloodstream infections: impact on mortality and role of combination therapy","volume":"42","author":"Boattini","year":"2023","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107808_bib0005","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jgar.2025.07.011","article-title":"Emerging resistance to novel \u03b2-lactam \u03b2-lactamase inhibitor combinations in Klebsiella pneumoniae bearing KPC variants","volume":"44","author":"Hamza","year":"2025","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.ijantimicag.2026.107808_bib0006","doi-asserted-by":"crossref","first-page":"S544","DOI":"10.1093\/cid\/ciz827","article-title":"In vitro activity of cefiderocol against a broad range of clinically important gram-negative bacteria","volume":"69","author":"Yamano","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107808_bib0007","doi-asserted-by":"crossref","first-page":"14132","DOI":"10.3390\/cimb46120846","article-title":"Updates on the activity, efficacy and emerging mechanisms of resistance to cefiderocol","volume":"46","author":"Bianco","year":"2024","journal-title":"Curr Issues Mol Biol"},{"key":"10.1016\/j.ijantimicag.2026.107808_bib0008","doi-asserted-by":"crossref","first-page":"1172.e7","DOI":"10.1016\/j.cmi.2021.04.016","article-title":"Cross-resistance to cefiderocol and ceftazidime-avibactam in KPC \u03b2-lactamase mutants and the inoculum effect","volume":"27","author":"Hobson","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2026.107808_bib0009","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s10096-021-04397-x","article-title":"Co-resistance to ceftazidime-avibactam and cefiderocol in clinical isolates producing KPC variants","volume":"41","author":"Poirel","year":"2022","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107808_bib0010","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1093\/jac\/dkac230","article-title":"Evaluation of a diagnostic algorithm for rapid identification of gram-negative species and detection of extended-spectrum \u03b2-lactamase and carbapenemase directly from blood cultures","volume":"77","author":"Comini","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107808_bib0011","first-page":"2068","article-title":"Prokka: rapid prokaryotic genome annotation","volume":"30","author":"Seeman","year":"2014","journal-title":"Bioinf."},{"key":"10.1016\/j.ijantimicag.2026.107808_bib0012","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1007\/s10096-024-04958-w","article-title":"In vivo development of resistance to novel \u03b2-lactam\/\u03b2-lactamase inhibitor combinations in KPC-producing Klebsiella pneumoniae infections: a case series","volume":"43","author":"Boattini","year":"2024","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2026.107808_bib0013","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1093\/jac\/dkad086","article-title":"Outbreak by KPC-62-producing ST307 Klebsiella pneumoniae isolates resistant to ceftazidime\/avibactam and cefiderocol in a university hospital in Madrid, Spain","volume":"78","author":"Castillo-Polo","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107808_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2023.107030","article-title":"Functional features of KPC-109, a novel 270-loop KPC-3 mutant mediating resistance to avibactam-based \u03b2-lactamase inhibitor combinations and cefiderocol","volume":"63","author":"Di Pilato","year":"2024","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2026.107808_bib0015","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3390\/pathogens13060507","article-title":"Complete genome sequence of a Klebsiella pneumoniae strain carrying novel variant blaKPC-203, cross-resistant to ceftazidime\/avibactam and cefiderocol, but susceptible to carbapenems, isolated in Italy, 2023","volume":"13","author":"Amadesi","year":"2024","journal-title":"Pathogens"},{"key":"10.1016\/j.ijantimicag.2026.107808_bib0016","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3390\/antibiotics13060507","article-title":"Detection of KPC-216, a novel KPC-3 variant, in a clinical isolate of Klebsiella pneumoniae ST101 co-resistant to ceftazidime-avibactam and cefiderocol","volume":"13","author":"Giufr\u00e8","year":"2024","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ijantimicag.2026.107808_bib0017","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00574-21","article-title":"Evolutionary trajectories toward ceftazidime-avibactam resistance in Klebsiella pneumoniae clinical isolates","volume":"65","author":"Carattoli","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107808_bib0018","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.03496-22","article-title":"Cefiderocol resistance in Klebsiella pneumoniae is linked to SHV extended-spectrum beta-lactamase activities and functional loss of the outer membrane porin OmpK35","volume":"11","author":"Moon","year":"2023","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.ijantimicag.2026.107808_bib0019","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1093\/jac\/dkaf048","article-title":"High-level cefiderocol and ceftazidime\/avibactam resistance in KPC-producing Klebsiella pneumoniae associated with mutations in KPC and the sensor histidine kinase EnvZ","volume":"80","author":"Findlay","year":"2025","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107808_bib0020","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01192-20","article-title":"Roles of the EnvZ\/OmpR two-component system and porins in iron acquisition in Escherichia coli","volume":"11","author":"Gerken","year":"2020","journal-title":"mBio"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092485792600097X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092485792600097X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T02:26:19Z","timestamp":1780626379000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092485792600097X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S092485792600097X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.107808","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vivo emergence of cross-resistance to ceftazidime\/avibactam and cefiderocol through selection of KPC variants in Klebsiella pneumoniae clinical isolates","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.107808","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107808"}}